CA1063022A - Medicament ophtalmique sous forme solide - Google Patents

Medicament ophtalmique sous forme solide

Info

Publication number
CA1063022A
CA1063022A CA215,644A CA215644A CA1063022A CA 1063022 A CA1063022 A CA 1063022A CA 215644 A CA215644 A CA 215644A CA 1063022 A CA1063022 A CA 1063022A
Authority
CA
Canada
Prior art keywords
pilocarpine
product
ophthalmic
eye
inserts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA215,644A
Other languages
English (en)
Other versions
CA215644S (en
Inventor
Edward M. Cohen
Wayne M. Grim
Richard J. Harwood
Gunvant N. Mehta
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA1063022A publication Critical patent/CA1063022A/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts or implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ceramic Products (AREA)
  • Materials For Medical Uses (AREA)
  • Hydrogenated Pyridines (AREA)
CA215,644A 1973-12-17 1974-12-10 Medicament ophtalmique sous forme solide Expired CA1063022A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42542673A 1973-12-17 1973-12-17
US51932374A 1974-10-31 1974-10-31

Publications (1)

Publication Number Publication Date
CA1063022A true CA1063022A (fr) 1979-09-25

Family

ID=27026681

Family Applications (1)

Application Number Title Priority Date Filing Date
CA215,644A Expired CA1063022A (fr) 1973-12-17 1974-12-10 Medicament ophtalmique sous forme solide

Country Status (25)

Country Link
JP (1) JPS5636173B2 (fr)
AT (1) AT333945B (fr)
AU (1) AU509331B2 (fr)
CA (1) CA1063022A (fr)
CH (2) CH611797A5 (fr)
DD (2) DD117349A5 (fr)
DE (2) DE2462081C3 (fr)
DK (1) DK137946B (fr)
EG (1) EG11698A (fr)
ES (2) ES432866A1 (fr)
FI (1) FI58433C (fr)
FR (1) FR2254350B1 (fr)
GB (2) GB1485150A (fr)
HK (1) HK30880A (fr)
HU (1) HU171803B (fr)
IE (1) IE40466B1 (fr)
IL (1) IL46209A (fr)
IT (1) IT1056094B (fr)
KE (1) KE3049A (fr)
LU (1) LU71490A1 (fr)
NL (1) NL167326C (fr)
NO (1) NO140489C (fr)
PH (2) PH10938A (fr)
RO (1) RO63070A (fr)
SE (1) SE408014B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076942A (en) * 1975-10-01 1978-02-28 Merck & Co., Inc. Crystalline dipilocarpinium pamoate
US4255415A (en) * 1978-11-22 1981-03-10 Schering Corporation Polyvinyl alcohol ophthalmic gel
JPS5758615A (en) * 1980-09-26 1982-04-08 Nippon Soda Co Ltd Film agnent and its preparation
NZ200429A (en) * 1981-04-30 1984-10-19 Smith & Nephew Ass Applicator for placing pharmaceutically active agent in contact with moist surface,e.g.,eye
US4604384A (en) * 1982-06-24 1986-08-05 Smith Robert A Pharmaceutical gel composition
CH667001A5 (de) * 1985-09-03 1988-09-15 Hugo Degen Untermatratze.
US5036046A (en) * 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
DE19508029C2 (de) * 1995-03-07 1997-10-09 Richard Prof Dr Sueverkruep Darreichungsform zur äußerlichen Applikation von ophthalmischen Arzneistoffen und Verfahren zur Herstellung derselben
JP5081413B2 (ja) * 2005-07-29 2012-11-28 参天製薬株式会社 固形組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム
EP2493459B1 (fr) * 2009-10-30 2016-08-24 Aton Pharma, Inc. Dispositifs d'administration de médicaments par voie oculaire
BE1030503B1 (fr) 2022-05-06 2023-12-04 Eyed Pharma Insert pour le traitement de la sécheresse oculaire
WO2023214027A1 (fr) 2022-05-06 2023-11-09 Eyed Pharma Insert pour le traitement des yeux secs
BE1030504B1 (fr) 2022-05-06 2023-12-04 Eyed Pharma Insert composite pour le traitement de la sécheresse oculaire

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same

Also Published As

Publication number Publication date
FI58433B (fi) 1980-10-31
SE7415248L (fr) 1975-06-18
FI58433C (fi) 1981-02-10
HU171803B (hu) 1978-03-28
DD121643A5 (fr) 1976-08-12
NO140489B (no) 1979-06-05
DK629774A (fr) 1975-08-25
RO63070A (fr) 1978-06-15
JPS5636173B2 (fr) 1981-08-22
HK30880A (en) 1980-06-13
DE2459391C3 (de) 1978-10-19
SE408014B (sv) 1979-05-14
GB1485149A (en) 1977-09-08
AT333945B (de) 1976-12-27
NO140489C (no) 1979-09-19
GB1485150A (en) 1977-09-08
ES451015A1 (es) 1977-08-16
IL46209A (en) 1978-03-10
CH611797A5 (en) 1979-06-29
DE2462081C3 (de) 1980-04-03
EG11698A (en) 1977-10-31
FR2254350B1 (fr) 1978-07-21
DK137946B (da) 1978-06-12
DK137946C (fr) 1978-12-11
AU509331B2 (en) 1980-05-08
DE2462081A1 (de) 1975-11-06
IL46209A0 (en) 1975-03-13
ATA996174A (de) 1976-04-15
IT1056094B (it) 1982-01-30
DD117349A5 (fr) 1976-01-12
CH609864A5 (en) 1979-03-30
DE2462081B2 (de) 1979-08-02
NL167326B (nl) 1981-07-16
NL167326C (nl) 1981-12-16
ES432866A1 (es) 1977-02-16
AU7623574A (en) 1976-06-10
FI352274A7 (fr) 1975-06-18
PH10938A (en) 1977-10-05
FR2254350A1 (fr) 1975-07-11
KE3049A (en) 1980-06-06
LU71490A1 (fr) 1975-08-20
DE2459391A1 (de) 1975-06-19
DE2459391B2 (de) 1978-02-09
NO744394L (fr) 1975-07-14
PH17250A (en) 1984-07-03
JPS50105814A (fr) 1975-08-20
IE40466B1 (en) 1979-06-06
IE40466L (en) 1975-06-17
NL7415883A (nl) 1975-06-19

Similar Documents

Publication Publication Date Title
US4179497A (en) Solid state ophthalmic medication
US3863633A (en) Composition containing a substance showing a topical effect on the eye, and a method of preparing the same
CA1063022A (fr) Medicament ophtalmique sous forme solide
US5766619A (en) Pharmaceutical dosage form for ocular administration and preparation process
DE3310079C2 (fr)
US3868445A (en) Dosage unit containing a substance showing a topical effect on the eye, and a method of preparing same
DE2547378C2 (fr)
US5556633A (en) Drug delivery ophthalmic insert and method for preparing same
US5888493A (en) Ophthalmic aqueous gel formulation and related methods
US3962414A (en) Structured bioerodible drug delivery device
US3867519A (en) Bioerodible drug delivery device
DE602005003957T2 (de) Mit doppelextrusionsverfahren hergestelltes augenimplantat
US4136173A (en) Mixed xanthan gum and locust beam gum therapeutic compositions
JPH02702A (ja) 生物分解性眼移植物
IE842596L (en) Hyaluronic acid derivatives
JPS6322516A (ja) 制御放出性医薬組成物
US20020172712A1 (en) Antiemetic, anti-motion sustained release drug delivery system
DE2505305A1 (de) Enzymatisch abbaubarer bioerodierbarer arzneimitteltraeger
EP0077261B1 (fr) Corps d'insertion ophtalmique biosoluble
US3968201A (en) Dosage unit containing a substance showing a topical effect on the eye, and a method of preparing same
JP2000506833A (ja) 斑水腫の治療
EP0108661A1 (fr) Insertions oculaires en hydroxypropyl cellulose stabilisées et procédé de stérilisation
CN116211804B (zh) 熊去氧胆酸脂质组合物及其应用
CN115737668B (zh) 一种甲钴胺眼用制剂及其应用
JPS597684B2 (ja) コラ−ゲンを用いた眼用徐放性制御医薬剤